- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/70 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Patent holdings for IPC class C07D 333/70
Total number of patents in this class: 146
10-year publication summary
|
15
|
8
|
9
|
12
|
10
|
6
|
14
|
15
|
6
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 460 |
8 |
| VALO Health, Inc. | 172 |
6 |
| Ctxt Pty Ltd | 52 |
5 |
| Astellas Pharma Inc. | 1087 |
4 |
| C&C Research Laboratories | 18 |
4 |
| Accent Therapeutics, Inc. | 23 |
4 |
| Pfizer Inc. | 3379 |
3 |
| Takeda Pharmaceutical Company Limited | 2711 |
3 |
| The Broad Institute, Inc. | 1798 |
3 |
| Curis, Inc. | 131 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2845 |
3 |
| University of Kansas | 871 |
3 |
| Vanderbilt University | 1894 |
3 |
| Wyeth | 380 |
3 |
| Vivace Therapeutics, Inc. | 30 |
3 |
| Dongbao Purple Star (Hangzhou) Biopharmaceutical Co., Ltd. | 15 |
3 |
| F. Hoffmann-La Roche AG | 7929 |
2 |
| Janssen Pharmaceutica N.V. | 3399 |
2 |
| Bayer AG | 3327 |
2 |
| Encysive Pharmaceuticals Inc. | 15 |
2 |
| Other owners | 77 |